Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)
Clinical trial NCT01723657 · COMPLETED
Trial details
- NCT number
- NCT01723657
- Sponsor
- Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2012-03-01
- Enrollment
- 862
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.